



Schistosoma mansoni immunomodulatory molecule Sm16/SPO-1/SmSLP is a member of 3 
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Background- Sm16, also known as SPO-1 and SmSLP, is a low molecular weight protein 33 
(~16kDa) secreted by the digenean trematode parasite Schistosoma mansoni, one of the main 34 
causative agents of human schistosomiasis. The molecule is secreted from the acetabular 35 
gland of the cercariae during skin invasion and is believed to perform an immune-suppressive 36 
function to protect the invading parasite from innate immune cell attack.  37 
Methodology/Principal Findings- We show that Sm16 homologues of the 38 
Schistosomatoidea family are phylogenetically related to the helminth defence molecule 39 
(HDM) family of immunomodulatory peptides first described in Fasciola hepatica. 40 
Interrogation of 69 helminths genomes demonstrates that HDMs are exclusive to trematode 41 
species. Structural analyses of Sm16 shows that it consists predominantly of an amphipathic 42 
alpha-helix, much like other HDMs. In S. mansoni, Sm16 is highly expressed in the cercariae 43 
and eggs but not in adult worms, suggesting that the molecule is of importance not only 44 
during skin invasion but also in the pro-inflammatory response to eggs in the liver tissues. 45 
Recombinant Sm16 and a synthetic form, Sm16 (34-117), bind to macrophages and are 46 
internalised into the endosomal/lysosomal system. Sm16 (34-117) elicited a weak pro-47 
inflammatory response in macrophages in vitro but also suppressed the production of 48 
bacterial lipopolysaccharide (LPS)-induced inflammatory cytokines. Evaluation of the 49 
transcriptome of human macrophages treated with a synthetic Sm16 (34-117) demonstrates 50 
that the peptide exerts significant immunomodulatory effects alone, as well as in the presence 51 
of LPS. Pathways most significantly influenced by Sm16 (34-117) were those involving 52 
transcription factors peroxisome proliferator-activated receptor (PPAR) and liver X 53 
receptors/retinoid X receptor (LXR/RXR) which are intricately involved in regulating the 54 
cellular metabolism of macrophages (fatty acid, cholesterol and glucose homeostasis) and are 55 
central to inflammatory responses. 56 
Conclusions/Significance- These results offer new insights into the structure and function of 57 
a well-known immunomodulatory molecule, Sm16, and places it within a wider family of 58 
trematode-specific small molecule HDM immune-modulators with immuno-biotherapeutic 59 




AUTHOR SUMMARY 63 
Sm16 is a low molecular weight protein (~16kDa) secreted by Schistosoma mansoni, a 64 
causative agent of human schistosomiasis. The molecule is secreted by the infectious 65 
cercariae during skin invasion and performs an immune-suppressive function to protect the 66 
invading parasite from immune attack. Using phylogenetic and gene structure analysis we 67 
show that Sm16 homologues of parasites belonging to the Schistosomatoidea superfamily of 68 
digenean worms are members of the helminth defence molecule (HDM) family that are 69 
potent immune-modulators and exclusive to trematode species. Structural analyses revealed 70 
that Sm16, much like other HDMs, consists predominantly of an amphipathic alpha-helix. 71 
Sm16 is highly expressed in the cercariae and eggs of S. mansoni but not male or female 72 
adult worms, suggesting that the molecule is of importance not only during skin invasion but 73 
also in the pro-inflammatory response to eggs in the liver tissues. A synthetic form of the 74 
molecule, termed Sm16 (34-117), was shown to bind to and enter immune cells 75 
(macrophages) and induce a weak pro-inflammatory response. However, this peptide also 76 
blocked the pro-inflammatory effects of bacterial endotoxin (lipopolysaccharide, LPS). 77 
Analysis of the transcriptome of Sm16 (34-117)-stimulated macrophages in the presence or 78 
absence of LPS suggests that it mediates immunomodulatory activity via signalling pathways 79 
that are intricately involved in regulating cellular metabolism (fatty acid, cholesterol and 80 
glucose homeostasis) and central to inflammatory responses. These new insights into the 81 
structure and function of a well-known immunomodulatory molecule, Sm16, places it within 82 
a wider family of trematode-specific small molecule HDM immune-modulators with 83 





Human schistosomiasis is a public health issue affecting approximately 200 million people in 88 
over 74 tropical/sub-tropical countries, with many more people at risk of infection [1]. The 89 
causative pathogens are digenean trematode parasites of the genus Schistosoma, mainly 90 
Schistosoma mansoni, S. japonicum and S. haematobium. Chronic schistosomiasis has a 91 
significant impact on morbidity and mortality as it affects the immune system, fertility, 92 
growth, and development throughout life [2].  93 
 94 
Schistosomiasis is acquired by contact with water containing free-swimming schistosome 95 
larvae, cercariae, that attach to and penetrate the skin. Itching or a rash on the skin can occur 96 
at the parasite’s point of entry. After a period of migration in the host, the worms mature to 97 
adults and reside as male-female pairs either in mesenteric venules (S. mansoni and S. 98 
japonicum) or in the venous plexus of the bladder (S. haematobium), where they produce 99 
approximately 300 (S. mansoni) to 3,500 (S. japonicum) eggs per day [3]. Eggs are passed 100 
through blood vessels and the wall of the digestive tract or the urinary bladder, where they 101 
are subsequently passed in faeces or urine into the environment. However, eggs can become 102 
lodged in intestinal or bladder tissue, and quite often the blood flow can displace the eggs and 103 
carry them to the liver where they become lodged in the tissue. 104 
 105 
Typically, a weak Th1-type response is observed during the initial stages of schistosomiasis 106 
before there is a shift towards a Th2-type response concurrent with the deposition of eggs in 107 
the tissues. Schistosome eggs are highly immunogenic and release soluble antigens (SEA) 108 
that can directly modulate antigen presenting cells and promote Th2-dominant responses, an 109 
immune environment that is key to the survival of adult parasites that evade expulsion for up 110 
to 40 years [3-5]. Egg-induced granulomas consisting of a mass of cells, mainly eosinophils, 111 
Th2-type CD4+ T-cells, and M2 macrophages, encapsulate the eggs [6,7]. While formation of 112 
granulomas is considered a protective mechanism to prevent excessive damage to host tissue, 113 
resolution of granulomatous tissue can cause considerable tissue fibrosis, particularly in cases 114 
of repeated and chronic infections [4,8]. 115 
 116 
Sm16 is a low molecular weight protein (~16 kDa) with immunomodulatory properties that is 117 
secreted by S. mansoni cercariae as they penetrate the host skin. Sm16 expression has been 118 
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described as stage-specific, with early reports indicating that it is expressed exclusively by 119 
sporocysts, cercariae, and early schistosomulae of S. mansoni [9,10]. Developmental 120 
expression analysis of S. japonicum suggested that the Sm16 homolog, Sj16, is enriched in 121 
eggs, miracidia, sporocysts, cercariae, and lung stage schistosomulae [11]. Recently, 122 
however, Bernardes et al. [12] reported that Sm16 is expressed in cercariae and newly 123 
transformed schistosomulae but not in adults or eggs. 124 
 125 
Sm16 inhibits TLR-3 and TLR-4 signalling in human monocytes [13] and the activation of 126 
macrophages in vitro [14] and suppresses leukocyte accumulation when administered to mice 127 
[15-17]. Sj16 peptide can inhibit lipopolysaccharide (LPS)-induced nitric oxide production 128 
by macrophages, block macrophage phagocytic and migratory activity, and dendritic cell 129 
maturation [18-20]. It has also been reported to induce IFN- and IL-10 secreting CD4+ 130 
CD25+ Foxp3+ regulatory T cell (Treg) populations both in vitro and in vivo [21]. This 131 
immunomodulatory activity of Sm16/Sj16 has shown promise as an anti-inflammatory 132 
therapy by suppressing cutaneous inflammation when administered intra-dermally [17], 133 
reducing the severity of Freund’s-induced arthritis in rats [22] and protecting against 134 
inflammatory colitis in a murine dextran sodium sulphite (DSS) model [23]. 135 
 136 
We have previously described a family of immunomodulatory molecules found in medically 137 
important flatworms such as Fasciola hepatica which we termed helminth defence molecules 138 
(HDMs) [24]. We showed that F. hepatica HDM (FhHDM-1) exhibits potent anti-139 
inflammatory properties; for example, it suppresses leukocyte accumulation and ameliorates 140 
inflammatory disease in pre-clinical murine models of type 1 diabetes and multiple sclerosis 141 
[25,26]. Here we describe phylogenetic, structural and functional links between Sm16 and 142 
HDM-like molecules and show that expression of these molecules is exclusive to trematode 143 
parasites. Our analysis verifies the expression of Sm16 in S. mansoni cercariae and eggs but 144 
not in adult male or female worms. We show that the C-terminal section of Sm16 is 145 
predominantly an uninterrupted amphiphilic -helix that may allow the peptide to penetrate 146 
cells and enter the endosomal/lysosomal system of macrophages. Sm16 activates various 147 
inflammatory responses in macrophages, but also has potent inhibitory activity against LPS-148 
induced inflammatory effects. RNA microarray and Ingenuity Pathway Analysis (IPA) 149 
predicted that several signalling pathways are affected by Sm16, most notably those 150 
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involving transcription factors, peroxisome proliferator-activated receptor (PPAR) and liver 151 
X receptors/retinoid X receptor (LXR/RXR), which are involved in regulating the cellular 152 
metabolism of macrophages and central to controlling inflammatory responses. Our findings 153 
provide valuable new insights into the role of Sm16 in host-parasite interactions at key stages 154 
of the schistosome life-cycle and place it amongst the wider family of trematode-specific 155 




MATERIALS AND METHODS 160 
Preparation of S. mansoni samples 161 
S. mansoni cercariae and livers from infected mice were a gift from the laboratory of Dr. 162 
Paula Ribeiro, McGill University. Mature S. mansoni were recovered from the mesenteric 163 
veins of infected mice (kindly provided by the Biomedical Research Institute, Rockville, 164 
Maryland, USA). Worms were transferred into DMEM for one to two hours at 37°C until the 165 
adult male and female were separated. Males and females were conserved separately at -80°C 166 
for protein extraction or in RNAlater (Ambion) for RNA extraction. Eggs were isolated from 167 
livers according to the procedure of Dalton et al. [27]. Infected mouse livers were also cut 168 
into small cubes and fixed in 4% paraformaldehyde in preparation for immunolocalization 169 
(see below). Serum was prepared from blood taken from mice infected with 35 cercariae at  170 
5-, 10- and 20-weeks post-infection. Animal procedures were reviewed and approved by the 171 
Facility Animal Care Committee of McGill University and were conducted in accordance 172 
with the guidelines of the Canadian Council on Animal Care. 173 
 174 
Proteins were extracted from cercariae, eggs, adult males and adult females with 200 µL of 175 
PBS pH 6.8 containing proteinase inhibitor cocktail (1 tablet/10ml; Roche, USA) using a pre-176 
chilled Dounce homogenizer. Mixtures were submitted to three freeze-thaw cycles in a 177 
freezer set to maintain -20°C. Total proteins were recovered by centrifuging 30 minutes at 178 
17,900 x g in a conventional tabletop microcentrifuge at 4°C. Protein concentrations were 179 
evaluated by Bradford assay.  180 
 181 
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Production of Sm16 by recombinant expression and chemical synthesis  182 
Recombinant Sm16 was produced in Pichia pastoris using the method previously described 183 
in Collins et al. [28]. The recombinant protein (residues 23-117, which excluded the signal 184 
sequence) was produced by fermentation at 30°C and 250-300 rpm in one litre BMGY broth 185 
buffered to pH 6.0 into 4 litre baffled flasks until an OD600 of 2-6 was reached.  The cells 186 
were centrifuged at 3,000 x g for 10 minutes at room temperature and the induction initiated 187 
by resuspending the pellets in 200 ml BMMY broth and adding 1% filter–sterilized methanol 188 
every 24 hours for 3 days.  The culture was then centrifuged at 16,000 x g for 30 minutes at 189 
RT. The pellets were discarded and Sm16 was isolated from the supernatant by Ni-NTA 190 
affinity chromatography. Recombinant S. mansoni cathepsin B1 (SmCB1) was produced in a 191 
similar manner as reported by Stack et al. [29]. 192 
A synthetic peptide corresponding to residues 34 to 117 of Sm16 (34-117) and 193 
various derivatives of this peptide were synthesised upon request by GL Biochem (Shanghai, 194 
China) and was dissolved in sterile, endotoxin-free water (Sigma Aldrich, UK) at 1 mg/ml 195 
and stored aliquoted at -80°C. 196 
 197 
Anti-Sm16 antibodies. 198 
Polyclonal antibodies were produced in rabbits against the peptide sequence 199 
‘MDKYIRKEDLGMKMLDVAKILGRRIEKRMEYIAKKC’ of Sm16 by Genscript (New 200 
Jersey, USA). The cysteine was added to the C-terminus to facilitate conjugation to 201 
ovalbumin. Antibodies were lyophilized prior to shipping and were resuspended in ultrapure 202 
water before the specific anti-Sm16 peptide antibody was purified by immune-affinity 203 
chromatography. The Sm16 peptides were covalently immobilized to a beaded agarose 204 
support using the SulfoLink Immobilization kit for peptides following the manufacturer’s 205 
recommendations (Thermo Scientific, USA).  206 
 207 
Phylogenetic analyses  208 
Homologous sequences were identified by TBLASTN analysis of the publically available 209 
genome databases at WormBase ParaSite (http://parasite.wormbase.org/index.html. 210 
Version: WBPS11) from 42 species of the phylum Nematoda and 27 species of phylum 211 
Platyhelminthes (S1 Table; S2 Table). BLAST analysis was based on the F. hepatica HDM 212 
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sequence (CCA61804) and the S. mansoni Sm16 sequence (AAD26122), in addition to 213 
previously characterised HDM and Sm16 sequences from Clonorchis sinensis, 214 
Opisthorchis viverrini and Schistosoma spp (S1 Table; S2 Table). Inclusion criteria for 215 
phylogenetic analysis were based on primary sequence alignments and confirmation of an 216 
amphipathic helix by helical wheel projections (HeliQuest). Protein alignments were carried 217 
out using MAFFT using the ginsi options [30], which was hand-edited using Geneious 218 
(v11.1.5; https://www.geneious.com) resulting in a contiguous sequence block ranging 219 
from Leu30 to Lys87 (FhHDM nomenclature) containing the amphipathic region of the 220 
proteins. Phylogenetic trees were constructed with PhyML 3.0 [31] using the phylogenetic 221 
model LG +G+I, with five random starting trees and 1000 bootstrap support. The final tree 222 
figures were generated using FigTree (http://tree.bio.ed.ac.uk/ software/figtree/). 223 
 224 
Structural analyses  225 
The signal peptide at the N-terminus of Sm16 was identified using the SignalP 4.1 server 226 
[32]. The amino acid sequence of Sm16 was entered into the I-TASSER server (accessible 227 
via. https://zhanglab.ccmb.med.umich.edu/I-TASSER/) to obtain an ab intitio prediction of 228 
the secondary structure. The I-TASSER server was also used to obtain a putative 3D model 229 
of secreted Sm16 [33]. The HeliQuest tool [34], was used to construct helical wheel 230 
projections. Circular dichroism (CD) spectra of recombinant Sm16 were recorded using a 231 
Jasco J-815 CD spectropolarimeter. Wavelength scans were performed between 190 and 250 232 
nm in 10 mM Tris, 50 mM NaF buffer (pH 7.3) in both the presence and absence of 233 
trifluoroacetic aid (TFE) [30% and 60% (v/v)] with a sample concentration of 100 µg/ml. 234 
Spectra were recorded in a 1 mm quart cuvette at 20°C. Data below 190 nM for the native 235 
Sm16 sample were removed from analyses due to low signal-to-noise.  236 
 237 
Cell culture 238 
The human acute monocytic leukaemia THP-1 cell line (ATCC, Manassas, USA) was 239 
routinely cultured (P2-30) in RPMI 1640 medium with ʟ-glutamine (2 mM) (Gibco, 240 
ThermoFisher Scientific, UK) supplemented with 10% (v/v) heat-inactivated foetal calf 241 
serum (FCS; Gibco, ThermoFisher Scientific, UK) and 1% (v/v) penicillin/streptomycin 242 
(PAA Laboratories GmbH, Pasching, Austria). Cells were seeded at a density of 2.5 x 105 243 
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cells/well in 24 well plates and were differentiated to macrophages by incubating with 2 ml 244 
of medium with 162 nM phorbol 12-myristate 13-acetate (PMA; Sigma Aldrich, UK) for 72 245 
hrs, then rested in fresh media (PMA-free) for 24 hrs before use. Cells were incubated with 246 
peptides (20 µg/ml) and/or LPS from Pseudomonas aeruginosa (100 ng/ml, Serotype 10, 247 
Source strain ATCC 27316; Sigma Aldrich, UK) in media for 16 hrs. 248 
 249 
Isolation and culture of bone marrow derived macrophages (BMDM) 250 
Bone marrow was harvested from C57BL/6 and Balb/c mice and differentiated into 251 
macrophages over 6 days in RPMI medium supplemented with 10% FCS, 252 
penicillin/streptomycin (100 U/ml), L-Glutamine (2 mM), 2-mercaptoethanol (2-ME; 50 µM) 253 
and macrophage colony-stimulating factor (M-CSF;50 ng/ml; eBiosciences). For 254 
experimentation, cells were counted by trypan blue exclusion, seeded at a density of 1.25 x 255 
105 cells/well, and left to adhere overnight. Cells were stimulated in fresh RPMI medium 256 
with 10% FCS, penicillin/streptomycin (100 U/ml), and L-Glutamine (2 mM) for 24 hrs. Cell-257 
free supernatants were collected for measurement of cytokines (stored at -20°C until 258 
required). For dose-dependency response studies, Balb/c bone marrow derived macrophages 259 
(5.0 x 105) were incubated for 30 min with full-length Sm16 (34-117) (5-50 μg/ml) and after 260 
washing in PBS were then stimulated with LPS (10 ng/ml) overnight. Ethical approval for 261 
these studies was granted by the University of Technology Sydney (UTS) Animal Care and 262 
Ethics Committee (Approval Number: 2017-1232) and experiments were conducted in 263 
accordance with the approved guidelines to be compliant with The Australian Code for the 264 
Care and Use of Animals for Scientific Purposes. 265 
 266 
RNA extraction, cDNA synthesis and qPCR 267 
Total RNA was extracted from adult males, adult females, mixed adults, eggs and cercariae 268 
using the miRNeasy Mini Kit (Qiagen, UK) according to the manufacturer’s instructions, 269 
eluted in 30 µl RNase-free water.  Assessment of RNA concentration and quality was carried 270 
out using the LVis plate functionality on the PolarStar Omega Spectrophotometer (BMG 271 
LabTech, UK). cDNA synthesis was carried out using the High capacity cDNA reverse 272 
transcription kit (ThermoFisher Scientific, UK) according to manufacturer’s instructions.   273 
 274 
Quantitative PCR (qPCR) reactions were performed in 20 µl reaction volumes in triplicate, 275 
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using 1 µl cDNA, 10 µl of Platinum® SYBR® Green qPCR SuperMix-UDG kit 276 
(ThermoFisher Scientific, UK) and 1 µM of each primer to amplify the  277 
Sm16 gene (Sm16_F 5’-CCGAGTGAAAAAGACATGGAAT-3’ and  278 
Sm16_R 5’-TCAATGCGTCTTCCAAGGAT-3’), and the constitutively expressed S. 279 
mansoni PAI gene (SmPAI_F 5’-ACGACCTCGACCAAACATTC-3’ and SmPAI_R 5’-280 
TAGCTCCGACAGAAGCACCT-3’). qPCR was performed using a Rotor-Gene 281 
thermocycler (Qiagen, UK), with the following cycling conditions: 95°C for 10 s, 50°C for 282 
15 s and 72°C for 20 s. Relative expression analysis was performed manually using Pfaffl's 283 
Augmented ΔΔCt method [35], whereby the comparative cycle threshold (Ct) values of the 284 
samples of interest are compared to a control and normalised to the PAI gene expression. The 285 
data are presented relative to the level of Sm16 expression in male adult schistosomes. 286 
Results were analysed using One Way ANOVA (version 6.00 for Windows, GraphPad 287 
Software); P-value <0.05 was deemed statistically significant.   288 
 289 
Immunolocalization in S. mansoni eggs 290 
Paraformaldehyde-fix liver sections were put into embedding cassettes and were dehydrated 291 
in sequential ethanol baths ranging from 50 to 100% with the last two steps in xylene 292 
substitute. Then, tissues were infiltrated with paraffin wax and blocks were placed on a 293 
cooling plate for 15 min to solidify. Five µm sections, cut using a microtome, were floated in 294 
a 45°C water bath and put on slides. Slides were allowed to dry at RT overnight before the 295 
immunolocalization procedure. 296 
 297 
For immunolocalization, slides were put in Safeclear (Xylene substitute; ThermoFisher 298 
Scientific, USA) three times for two minutes. They were subsequently rehydrated by 299 
sequential dipping in ethanol ranging from 100% to 20% with a final step in water. Sections 300 
were treated for two hours at RT in 2% BSA-PBS. They were then incubated overnight at 301 
4°C with rabbit anti-Sm16 (1:100). After three washes of five minutes in PBS, tissues were 302 
incubated for 1 hour with the Alexa Fluor 488-conjugated anti-rabbit (Invitrogen, USA; 303 
1:1000) in 2% BSA-PBS at RT and protected from light.  After a wash of five minute in PBS, 304 
DAPI (dilactate; Invitrogen, USA; 1:750 in PBS) was added and incubated for five minutes at 305 
RT. Tissues were washed three times for five minutes with PBS and mounted with 306 
PERMOUNT with a drop of mounting media. Confocal microscopy was performed with a 307 
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BIO-RAD RADIANCE 2100 confocal laser scanning microscope (CLSM) equipped with a 308 
Nikon E800 fluorescence microscope for confocal image acquisition and the LASERSHARP 309 
2000 software package.  310 
 311 
Internalisation of Sm16 by BMDMs 312 
BMDMs (7 x 106) were treated with 10 μg/ml of Alexa Fluor 488-conjugated (Life 313 
Technologies, Vic Australia) recombinant Sm16 or peptide Sm16 (34-117) for 30 min at 314 
37ºC then washed and fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton-315 
X/PBS. Samples were also stained with DAPI for identification of the cell nucleus. To follow 316 
internalisation of Sm16 (34-117), BMDMs (7x106) were simultaneously incubated with 10 317 
μg/ml of Alexa Fluor 488-labelled Sm16 (34-117) and 60 nM LysoTracker (Life 318 
Technologies, Vic, Australia) and imaged live after 30 min at 37ºC as described by Robinson 319 
et al. [36]. 320 
 321 
Immunoblot with infected mouse sera  322 
To analyse the proteins by immunoblotting they were first resolved by 12% SDS-PAGE.  323 
Proteins were transferred to nitrocellulose using a semi-dry blotting apparatus. The 324 
nitrocellulose membrane was blocked for 1hr at RT with 15 ml of 5% milk in TBS/0.05% 325 
Tween-20. Then, 15ml of 2.5% milk in TBS/0.05% Tween-20 containing the primary 326 
antibody (anti-Sm16 or serum from infected mice) was added to the nitrocellulose membrane 327 
for 1 hr, with rotation at RT. The nitrocellulose was washed three times for five min each 328 
with TBS/0.05% Tween-20 and then incubated in 15 ml of secondary antibody-peroxidase 329 
conjugate in TBS/0.05%-Tween for 1hr at RT. The nitrocellulose was washed three times for 330 
five min each with TBS/0.05 Tween-20 and then incubated in 15 ml of secondary antibody-331 
peroxidase conjugate in TBS/0.05%-Tween for 1 hr at RT. The nitrocellulose filter was again 332 
washed three times for five min each. Bound antibody was visualized by adding 1 ml of each 333 
reagent of SuperSignal West Femto Chemiluminescence Substrate (ThermoFisher Scientific, 334 
USA) for 5 minutes. The membrane was dried and developed in the dark using the 335 
autoradiography cassette and Kodak X-OMAT 2000 processor system.  336 
 337 
Cytokine analysis 338 
Human cytokines were measured using human IL-6 uncoated ELISA kit (Invitrogen, 339 
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ThermoFisher Scientific, UK), human TNF standard ABTS ELISA kit (Peprotech, London, 340 
UK), and human IL-8 ELISA MAX standard kit (Biolegend, San Diego, CA, USA) 341 
according to the manufacturers’ instructions. Cytokine arrays used were Human Cytokine 342 
Array C3 (RayBiotech, Norcross, GA, USA). The levels of mouse cytokines present in 343 
culture supernatants were quantified using an ELISA (BD Pharmingen, North Ryde, NSW, 344 
Australia), according to the manufacturer’s instructions. 345 
 346 
RNA microarrays 347 
Cells obtained from three independently performed experiments were lysed in 400 μl 348 
TRIzol® Reagent (ThermoFisher Scientific, UK) and RNA was purified using PureLink 349 
RNA Mini Kit (ThermoFisher Scientific, UK). RNA integrity number (RIN) scores were 350 
determined using RNA 6000 nano gel matrices (Agilent Technologies, Santa Clara, CA, 351 
USA). Microarray analysis of RNA (100 ng/μl; RIN score ≥ 9.9) was carried out using 352 
Human HT-12 v4 BeadChips (Illumina, San Diego, CA, USA). Differential gene expression 353 
analysis was carried out using Partek Genomics Suite (PGS) version 6.6 (Partek 354 
Incorporated, Chesterfield, MO, USA). Genes were filtered for fold change in > 1.5 and < -355 
1.5 and an expression p-value <0.05. False discovery rate (FDR) correction was not applied. 356 
The canonical pathway and comparison analyses were generated through the use of 357 
Ingenuity® Pathway Analysis (IPA) (QIAGEN Inc., 358 
https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis).  359 
 360 
Statistical analysis 361 
Results were analysed using one-way ANOVAs with Tukey’s multiple comparison test. 362 
Differences were not deemed significant when p-values (p) >0.05. *p <0.05, **p <0.01, ***p 363 




Schistosome Sm16 is a helminth defence molecule (HDM)  368 
Analysis of genomic data available on WormBase ParaSite facilitated the identification of a 369 
number of homologues of Sm16 and HDMs. Most notably, these molecules were identified 370 
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solely in the genomes of trematode species (i.e. no HDMs were discovered in the genomes of 371 
any cestode or nematode). Phylogenetic analysis of the HDM sequences recovered from the 372 
various trematode genomes demonstrates a very close relationship between Sm16-like 373 
molecules and Fasciola-like HDMs. However, Sm16-like molecules form a distinct branch 374 
and are exclusively produced by organisms of the Schistosomatoidea superfamily, some of 375 
which, for example S. japonicum, express several members.  We have termed these the 376 
Sm16-like HDMs. 377 
 378 
The Fasciola-like HDM branch of the phylogenetic tree (Fig. 1) currently contains HDMs 379 
from F. hepatica, Echinostoma caproni, Clonorchis sinensis and Opisthorchis vivverrini 380 
which cluster together. It also contains HDMs from various species of the Schistosomatoidea 381 
superfamily; however, these form a separate extended branch. We have termed these the 382 
Fasciola-like HDMs. 383 
 384 
Fig.1. HDMs are a trematode-specific family of immunomodulatory peptides inclusive of Sm16-385 
like molecules.  386 
Midpoint-rooted maximum likelihood phylogram of the trematode-specific HDM family generated by 387 
PhyML, based on the protein sequence Leu30 to Lys87 (FhHDM nomenclature) containing the 388 
amphipathic region of the proteins from 12 trematode species: Clonorchis sinensis (CsHDM_1), 389 
Echinostoma caproni (EcHDM_1.1 & EcHDM_1.2), Fasciola hepatica (FhHDM_1), Opisthorchis 390 
viverrini (OvHDM_1), Schistosoma curassoni (Sc16 & ScHDM_2), S. haematobium (Sh16 & 391 
ShHDM_2), S. japonicum (Sj16_1, Sj16_2, Sj16_3, SjHDM_1 & SjHDM_2), S. mansoni (Sm16, 392 
SmHDM_1 & SmHDM_2), S. margrebowiei (Smrz16), S. mattheei (Smtd16), S. rodhaini (Sr16, 393 
SrHDM_1 & SrHDM_2) and Trichobilharzia regenti (Tr16_1, Tr16_2 & TrHDM_2). The clusters of 394 
Sm16-like HDMs and Fasciola-like HDMs are shown. Bootstrap support values (1000 iterations) are 395 
shown at each node. Accession number/gene identifiers are presented in S1 Table.  396 
 397 
The evolutionary relationship between members within the Sm16-like HDMs and Fasciola-398 
like HDMs is also supported by their genomic organization; the structure of the genes from 399 
both groups feature four exons separated by three introns of similar lengths. The first exon 400 
encodes the secretory signal peptide. There is a particularly high degree of sequence 401 
conservation in the third and fourth exons across all of the gene sequences that encodes the 402 
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C-terminal region of the protein which is comprised mainly of -helix secondary structure 403 
(S1 Fig, S2 Fig; discussed below). 404 
 405 
Structural analysis of Sm16 reveals an amphipathic -helical molecule 406 
Analysis of the amino acid sequence of Sm16 using I-TASSER indicated that much of the 407 
molecule is helical in structure (Fig. 2A and B). This was further confirmed by circular 408 
dichroism analysis of the recombinant Sm16 produced in Pichia pastoris (Fig. 2C; S3 Fig.). 409 
Further analysis of the sequence using helical wheel projections (HeliQuest) indicated that 410 
the C-terminal half of Sm16 (residues 52-114) is predominantly uninterrupted amphiphilic -411 
helix containing four hydrophobic hotspots (Fig. 2D). As mentioned above, this C-terminal 412 
section of the protein is highly conserved between the Sm16-like molecules of the 413 
Schistosomatoidea and is encoded by the third and fourth exons of their genes (S1 Fig.).  414 
 415 
Fig.2. Sm16 predominantly consists of an amphipathic alpha helix. 416 
(A) Predictive secondary structure of Sm16 generated using I-TASSER:  H – Helix; S – Strand; C – 417 
coil. Arrow (i) denotes the SignalP 4.1 predicted cleavage site for an N-terminal secretory signal 418 
peptide between residues 22 and 23, and arrow (ii) shows the commencement of the synthetic Sm16 419 
(34-117) peptide sequence. The black line indicates the portion of Sm16 that is amphipathic. (B) 3D 420 
model of full length secreted Sm16, generated using I-TASSER (C) Circular dichroism analysis 421 
performed on recombinant Sm16 in the absence of tetrafluoroethylene (TFE), in 30% TFE, and 60% 422 
TFE. (D) Helical wheel analysis of Sm16 performed using HeliQuest identified four hydrophobic 423 
faces (indicated by blue line through helix) in continuous succession in the amphipathic C-terminal 424 
helix. <H> - Hydrophobicity; <μH> - Hydrophobic Moment.  425 
 426 
Sm16 is expressed predominantly in S. mansoni cercariae and eggs  427 
To investigate Sm16 expression in the stages of S. mansoni that exist in the mammalian host, 428 
qPCR was performed on mRNA extracted from adults (males, females, and both male and 429 
female mixed), cercariae, and eggs. Sm16 transcription was significantly higher in both S. 430 
mansoni cercariae and egg samples compared to adult male worms. Low levels of Sm16 431 
expression were observed within the female worms and while higher than in males these 432 
levels were not statistically different (Fig. 3A). Anti-Sm16 antibodies, raised against a 433 
synthetic peptide derived from Sm16 (residues 34-117) was used to probe a Western blot 434 
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containing S. mansoni adults (mixed, males, and females), cercariae, and egg crude extracts. 435 
Sm16 was not detected in the adult worm samples, consistent with the data derived from 436 
qPCR (Fig. 3B). Sm16 was most abundant in cercariae and was detected in eggs when the 437 
immunoblots were exposed for longer periods (see Fig. 3B). Cercariae mechanically-438 
transformed into schistosomules along with the concentrated transformation medium were 439 
also probed with anti-Sm16 antibodies. This analysis identified Sm16 in both parasite stages 440 
and in the medium demonstrating that Sm16 is released from the cercariae during the 441 
transformation process (Fig. 3C). It is worth noting that mature Sm16 has a lower molecular 442 
weight with reports calculating the mature secreted protein to be between 11.3-11.7 kDa in 443 
size [10,18], but it can run slightly higher on SDS-PAGE 444 
 445 
Fig 3. Sm16 is expressed in S. mansoni cercariae and eggs.  446 
(A) qPCR was used to assess the expression of Sm16 mRNA in S. mansoni adults (males, females, 447 
and mixed), cercariae and eggs. ΔΔCt values were normalised to the level of PAI expression in 448 
samples (3) and presented as relative to the level of Sm16 expression in male adult schistosomes and 449 
analysed by ANOVA with Tukey’s multiple comparison test. *p <0.05, **p <0.01. (B) Western blot 450 
carried out using 5 µg of crude extract from S. mansoni adults (mixed, females and males) cercariae 451 
and eggs and probed with an anti-Sm16 antibody. (C) SDS-PAGE analysis (lanes 1-4) and Western 452 
blot (5 -8) of soluble extracts of cercariae (1 and 5), newly-transformed schistosomula (2 and 6), 453 
concentrated transformation medium (3 and 7) and recombinant Sm16 (4 and 8) (D) Blood samples 454 
were taken from mice with experimental schistosomiasis at 0, 5, 10, and 20 weeks post infection and 455 
sera was used to probe Western blots of recombinant Sm16, synthetic peptide Sm16 (34-117), and 456 
recombinant S. mansoni cathepsin B1 (SmCB1) (1 µg of each). 457 
 458 
Sm16 is immunogenic in S. mansoni-infected mice, but only late in infection 459 
In order to determine if Sm16 is immunogenic during infection, mice were experimentally 460 
infected with 35 S. mansoni cercariae and serum samples harvested at 0-, 5-, 10- and 20-461 
weeks post-infection were used to probe Western blots containing recombinant Sm16 and 462 
synthetic Sm16 (34-117). Recombinant S. mansoni cathepsin B1 (SmCB1), an immunogenic 463 
protease that is produced and secreted abundantly by intra-mammalian S. mansoni [37] was 464 
used as a positive control. The immunoblots showed that circulating antibodies to SmCB1 are 465 
present as early as week five post-infection and remain high at week 10 and 20 post-466 
infection. However, neither recombinant nor synthetic Sm16 preparations were detected on 467 
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blots that were probed with serum obtained from mice at 5 and 10 weeks after infection but 468 
were strongly reactive with serum taken at 20 weeks post-infection (Fig. 3D). 469 
 470 
Sm16 is detected in eggs in S. mansoni-infected mice 471 
S. mansoni eggs were identified in sections of liver tissue from mice that had been 472 
experimentally infected with S. mansoni for seven weeks (Fig. 4). Immunofluorescent 473 
imaging by means of probing with anti-Sm16 antibody followed by Alexa Fluor 488-474 
conjugated anti-rabbit antibodies was used to confirm the presence of Sm16 in S. mansoni 475 
eggs. Anti-Sm16 antibody binding was clearly observed within the unembryonated 476 
miracidium in the eggs. No labelling was observed within eggs using control mouse serum. 477 
 478 
Fig.4. Immunolocalisation of Sm16 in S. mansoni eggs  479 
Paraffin was embedded liver sections of S. mansoni-infected (7 weeks post-infection) containing S. 480 
mansoni eggs were probed with anti-Sm16 antibody represented by green fluorescence. For the 481 
negative controls (Ctl) the anti-Sm16 antibodies were first adsorbed with an excess of recombinant 482 
Sm16 prior to being used in the protocol. Nuclear staining was carried out using DAPI represented by 483 
blue fluorescence. The Trans panels shows the sections under light microscopy. 484 
 485 
Sm16 (34-117) is taken up by macrophages and co-localises with the endo-lysosomes 486 
The Fasciola-like HDMs are known to mediate at least a part of their immune modulatory 487 
effect through interaction with macrophages. To determine whether the Sm16 peptides had 488 
the same potential, we visualised the uptake of Alexa Fluor 488-conjugated recombinant 489 
Sm16 and synthetic Sm16 (34-117) by murine macrophages (Fig 5A & B, respectively). Both 490 
recombinant and peptide were clearly internalised by the macrophages, presented as punctate 491 
fluorescence in the cytoplasm fifteen minutes after their addition to cells in culture. 492 
Furthermore, the co-localisation of Sm16 (34-117)-conjugated fluorescence with Lysotracker 493 
indicated that the peptides were located within the endo-lysosomal system of macrophages 494 
(Fig 5C). The labelling with anti-Sm16 appeared more extensive within the 495 
endosomal/lysosomal system than Lysotracker since the latter only fluoresces within the 496 
more acidic mature lysosomes. 497 
 498 
Fig. 5. Sm16 is internalised by macrophages.  499 
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(A) BMDMs (7 x 106) were untreated (Un) or incubated with 10 µg/ml Alexa Fluor 488-conjugated 500 
recombinant Sm16 (Sm16) in media for 30 min at 37°C, 5% CO2, prior to fixation with 4% PFA. 501 
Samples were also stained with DAPI for identification of the cell nucleus. (B) BMDMs (7 x 106) 502 
were untreated (Un) or incubated with 10 µg/ml Alexa Fluor 488-conjugated synthetic Sm16 (34-117) 503 
(Sm16) in media for 30 min at 37°C, 5% CO2, prior to fixation with 4% PFA. (C) BMDMs (7x106) 504 
were incubated with Alexa 488-conjugated recombinant Sm16 (10µg/mL) in media with 60 nM 505 
LysoTracker for 30 min at 37°C, 5% CO2. Visual identification of fluorescence in the respective 506 
channels was used to construct the panels; Sm16 staining shown in green, DAPI staining in blue and 507 
LysoTracker staining shown in red. Co-localization identification was confirmed by automated 508 
analysis using the NIS software. Scale bar: 5μM. 509 
 510 
Sm16 (34-117) affects cytokine production by macrophages 511 
To evaluate the effects of Sm16 (34-117) on the inflammatory responses of human 512 
macrophages, we analyzed supernatants of THP-1 macrophages treated with Sm16 (34-117) 513 
and LPS using a broad cytokine array (S3 Table). The data showed that Sm16 (34-117) alone 514 
increased secretion of cytokines including IL-6, IL-1β, GM-CSF, I-309, TNF, and IL-10. 515 
Stimulation with LPS alone also increased secretion of these cytokines; however, the 516 
quantities of IL-6, GM-CSF, TNF were higher than in the macrophages stimulated by Sm16 517 
(34-117) while induction of IL-1β and I-309 were lower and IL-10 the same. Therefore, both 518 
Sm16 and LPS induce a pro-inflammatory response from THP-1 macrophages, albeit with 519 
some differences. However, addition of Sm16 (34-117) to THP-1 cells alongside LPS 520 
suppressed the induction of the LPS-induced inflammatory response in macrophages (S3 521 
Table).  522 
 523 
To further validate these observations, we measured IL-6 and TNF by ELISA in supernatants 524 
of THP-1 macrophages treated with Sm16 (34-117) alone, LPS alone and both together. Cells 525 
treated with Sm16 (34-117) alone did not secrete TNF but did secrete higher levels of IL-6 526 
compared to untreated controls, although this increase was not statistically significant (Fig. 527 
6A). This weak pro-inflammatory effect of Sm16 (34-117) was also observed using BMDMs 528 
from C57/BL6 and Balb/c mice (data not shown). By contrast, LPS stimulation elicited a 529 
highly significant increase in levels of IL-6 and TNF secreted by THP-1 macrophages. 530 
Addition of Sm16 (34-117) to LPS-treated cells significantly reduced the amount of IL-6 and 531 
TNF released (Fig. 6A).  532 
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 533 
Fig. 6.  Effects of synthetic peptide Sm16 (34-117) treatment on cytokine secretion by 534 
macrophages. 535 
(A) IL-6 and TNF in cell supernatants of THP-1 macrophages (2.5 x 105) treated with Sm16 (34-117) 536 
(20 μg/ml), LPS (100 ng/ml) and Sm16 (34-117) + LPS for 16 hrs were quantified by ELISA. Data 537 
derived from three independently performed experiments was analysed using repeated measures 538 
ANOVA with Tukey’s multiple comparison test. (B) Sm16 (34-117) inhibits macrophage activation 539 
in a dose-dependent manner. Bone marrow derived macrophages (5.0 x 105) from Balb/c mice were 540 
incubated for 30 min with full-length Sm16 (34-117) (5-50 μg/ml) and after washing in PBS were 541 
then stimulated with LPS (10 ng/ml) 16h. TNF and IL6 in cell supernatants was measured by ELISA. 542 
(C-D) Effect of Sm16 (34-117) and small peptides derivatives from the C-terminal amphipathic helix. 543 
THP-1 cells were treated with 20 μg/ml of Sm16 (52-77), Sm16 (60-80), Sm16 (73-107), Sm16 (85-544 
96), Sm16 (85-115), or Sm16 (95-115) in the absence (C) and presence (D) of LPS stimulation (100 545 
ng/ml). IL6 in cell supernatants was measured by ELISA. Data analysed by ANOVA with Tukey’s 546 
multiple comparison test as above. *p <0.05, **p <0.01, ***p <0.001. 547 
 548 
Studies were performed with BMDMs from Balb/c mice to demonstrate that the effect of 549 
Sm16 was not restricted to THP-1 cells. In addition, to exclude the possibility of the anti-550 
inflammatory effects of Sm16 (34-117) resulting from its direct binding to LPS (especially at 551 
high doses) we incubated BMDMs with Sm16 (34-117) at a range of concentrations (5-50 552 
g) for 30 min before washing the cells and subsequently adding LPS. Cell supernatants were 553 
collected following an overnight incubation and the quantities of TNF and IL6 in samples 554 
were measured by ELISA (Fig. 6B). Sm16 (34-117) inhibited macrophage activation in a 555 
dose-dependent manner (5 - 50 μg/ml). Our data shows, therefore, that Sm16 can effectively 556 
modulate the inflammatory response of these murine macrophages and human THP-1 cells to 557 
stimulation with LPS. 558 
 559 
To determine if the conserved -helix region held the immune modulating activity of Sm16 560 
and to identify a smaller effective anti-inflammatory peptide, we synthesised peptides 561 
corresponding to the following residues, Sm16 (52-77), Sm16 (60-80), Sm16 (73-107), Sm16 562 
(85-96), Sm16 (85-115), or Sm16 (95-115), and tested these against THP-1 cells. We used 563 
IL-6 as our measure of blocking activity since microarray data showed that this cytokine was 564 
affected to a greater degree by Sm16 (52-77) than TNF (fold change of 309 vs 14.9, S3) and 565 
its secretion from LPS-stimulated THP-1 cells was effectively blocked by Sm16 (52-77) (Fig. 566 
 19 
6A). Compared to the parent Sm16 (34-117), none of these peptide derivatives significantly 567 
induced IL-6 secretion directly from THP-1 macrophages (Fig. 6C). Moreover, no peptide 568 
significantly blocked the pro-inflammatory effect of LPS (Fig. 6D). 569 
 570 
Changes to human macrophage gene expression exerted by Sm16 (34-117)  571 
To investigate the effects of Sm16 (34-117) on human macrophage gene transcription, THP-1 572 
macrophages were incubated with Sm16 (34-117), LPS, or LPS and Sm16 (34-117) and 573 
mRNA transcripts analysed using Illumina HT12 V.4 Expression Bead Chips. In cells treated 574 
with Sm16 (34-117) only, transcription of a total of 1217 genes was significantly (p<0.05) 575 
changed: 751 gene transcripts exhibited increased expression (>1.5 fold) and 466 were down-576 
regulated (<-1.5 fold) (Fig. 7A; see S4 Table for top 70 genes differentially regulated by 577 
Sm16).  LPS treatment significantly affected the transcription of 1855 genes, 486 of which 578 
showed increased expression while 1369 decreased (Fig. 7A).  579 
 580 
Fig. 7. Sm16 (34-117) treatment significantly alters gene expression in THP-1 macrophages. 581 
THP-1 macrophages (2.5 x 105) were treated with Sm16 (34-117) (20 μg/ml) and/or LPS (100 ng/ml) 582 
or not treated (Untreated) for 4 hrs before extracting RNA for analysis using Illumina HT12 V.4 583 
Expression Bead Chips. Significantly (p <0.05) differentially expressed genes were identified by 584 
ANOVA when analysing Sm16 vs Untreated; LPS vs Untreated; Sm16 + LPS vs LPS alone. Data is 585 
derived from three independently performed experiments. (A) Overview of differential gene 586 
expression analyses detailing total number of genes that were up- and down-regulated >1.5 fold and 587 
<-1.5 fold, represented by orange and blue bars, respectively. (B) Venn diagram depicting overlap of 588 
differentially expressed genes across the respective analyses. (C) Canonical pathways predicted to be 589 
affected by the respective treatments as determined by IPA analysis of the differentially expressed 590 
genes (± 1.5 fold change). Inhibition and activation of pathways are shown by the z-score, represented 591 
by a scale of blue to orange, respectively. 592 
 593 
Of the 1217 genes for which expression was changed significantly by Sm16 (34-117), 65% 594 
(795) overlapped with the genes significantly changed by LPS stimulation. The directionality 595 
of the genes in this cohort was identical across the two sets of differential gene expression 596 
analyses, i.e. the same genes were up- or down-regulated in each group. Analysis of the 597 
remaining 35% (422) of genes that exclusively responded to Sm16 (34-117) revealed that 598 
these genes are most highly associated with cellular movement and development, 599 
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inflammatory responses and tissue morphology. Based on their differential expression, IPA 600 
indicates that Sm16 is likely to cause an increase in lymphocyte populations, increase cell 601 
viability, cellular movement and phagocytosis, as well as a decrease in myeloid cell 602 
populations and inflammatory responses (S4 Fig.). 603 
 604 
THP-1 macrophages treated with LPS and Sm16 (34-117) showed transcriptional changes in 605 
only 106 genes compared to cells treated with LPS alone: of these, 37 genes showed >1.5 606 
fold increased expression, while 69 <-1.5 fold decreased in expression (Fig. 7A and C; see 607 
also S5 Table for top 70 genes differentially regulated by LPS followed by Sm16). A full list 608 
of the differential expression analyses results can be found in S6 Table. 609 
 610 
Based on the differential changes to gene expression, Ingenuity Pathway Analysis (IPA) 611 
predicted that the pathways most negatively affected by treatment of the macrophages with 612 
either Sm16 (34-117) or LPS are nuclear receptors PPAR and LXR/RXR. These transcription 613 
factors are intricately involved in regulating cellular metabolism of macrophages (fatty acid, 614 
cholesterol and glucose homeostasis) and are central to the modulation of innate immune cell 615 
fate [38,39] (Fig. 7C). However, when cells were first treated with LPS and then followed by 616 
Sm16 (34-117) both of these signaling pathways were up-regulated (Fig. 7C). Conversely, 617 
several inflammatory signaling pathways including dendritic cell maturation, NF-κB 618 
signaling, HMGB1 signaling, acute phase responses, and IL-6 are putatively activated by 619 
Sm16 (34-117) and LPS alone, and are inhibited when cells are first treated with LPS and 620 
then with Sm16 (34-117) (Fig. 7C).  621 
 622 
The predicted implications of the changes to gene expression exerted by Sm16 (34-117) 623 
alone on the biological processes of macrophages include increased leukocyte activation and 624 
adhesion, chemotaxis, inflammatory responses and cell and organismal survival (S5 Fig.). 625 
Sm16 (34-117), however, showed differences with LPS most obviously in its suppression of 626 
biological functions associated with morbidity/mortality and organismal death that were 627 
activated by LPS. These results further emphasise that while the Sm16 (34-117) itself can 628 
activate various inflammatory responses in macrophages it also has potent inhibitory activity 629 
against LPS-induced inflammation. 630 
631 
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DISCUSSION  632 
Phylogenetic, structural and functional analysis of the well-known schistosome-secreted 633 
molecule, Sm16, provides strong evidence for its inclusion within the helminth defence 634 
molecule (HDM) family of immunomodulators. Previously, our clustal analysis of several 635 
members of HDMs suggested an evolutionary link between Sm16 and HDMs [40]. Given the 636 
extensive range of genomic data now available for helminth species, a more thorough 637 
phylogenetic analysis was carried out and confirmed these previous findings. Gene structure 638 
analysis further supported the expansion of this family of Sm16-like molecules by 639 
demonstrating a conserved intron-exon pattern amongst the HDM and Sm16 genes. 640 
 641 
Furthermore, we found that Sm16-like HDMs form a distinct branch of the HDMs specific to 642 
the Schistosomatoidea superfamily which is consistent with the early evolutionary divergence 643 
of this superfamily from the other trematode families [41]. Sequence alignments of Sm16 644 
homologues in S. japonicum, S. haematobium, S. curassoni, S. margrebowiei, S. mattheei, S. 645 
rodhaini, and Trichobilharzia regenti, showed that Sm16-like molecules are structurally 646 
highly conserved within this superfamily. Since the Schistosomatoidea superfamily also 647 
express members of the Fasciola-like HDMs it is clear that the two branches arose from a 648 
common ancestral HDM. Therefore, these analyses verify the view that the Sm16-like HDMs 649 
diverged to perform a function(s) that is unique to Schistosomatoidea, most obviously, a role 650 
in the process of skin invasion by cercariae which is unique to this trematode superfamily.  651 
 652 
Looking more broadly, our genomic searches also discovered that the HDM family of 653 
molecules are exclusively present in the genomes of trematode species. All trematode 654 
genomes examined possessed at least one HDM-encoding gene whereas these were absent 655 
from all nematode and cestode genomes. Such conservation within trematode species 656 
indicates that HDM molecules are of great importance to the development and/or survival of 657 
these digenean endoparasites. Our studies with F. hepatica (FhHDM/FhMF6p) have 658 
suggested that trematodes secrete HDMs to modulate the host immune responses to ensure 659 
their longevity, possibly by preventing the activation of pro-inflammatory responses via the 660 
inflammasome [42]. Another idea proposed by Martinez-Sernandez et al. [43] relates to the 661 
heme-binding property of FhHDM/FhMF6p and suggests that they play a role in the 662 
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scavenging of potentially damaging free heme released from haemoglobin during feeding by 663 
the parasites.  664 
 665 
Structural analysis of the Sm16 protein demonstrates that it is primarily an -helical 666 
molecule. We highlighted the presence of four consecutive hydrophobic faces in the major -667 
helical region that spans much of the Sm16 C-terminal section (residues 52-115). 668 
Hydrophobic residues were concentrated on one face of each -helix and indicate that Sm16 669 
is considerably amphipathic. This shows that the structural and biochemical properties of the 670 
Sm16-like and Fasciola-like HDMs are also very similar in that they are -helical, 671 
amphipathic, and cationic [24]. Indeed, the integrity of the C-terminal sequence and structure 672 
of these molecules appears to be inherently important for their immunomodulatory activity. 673 
Truncation or disruption of the Sm16 sequence at the C-terminus impairs its ability to bind to 674 
surface membranes and to be internalised by mammalian cells [14,20,44], which has also 675 
been observed in our studies on F. hepatica FhHDM/FhMF6p [36].  676 
 677 
The first studies of Sm16 two decades ago found that it was expressed exclusively by 678 
sporocysts, cercariae, and early schistosomulae of S. mansoni [9,10]. We also found that 679 
Sm16 constitutes a considerable proportion of the proteins in cercariae and, in keeping with 680 
the proteomic studies by Curwen et al. [45], is secreted during the mechanical transformation 681 
of cercariae to schistosomulae. The molecule is stored in abundance within the acetabular 682 
glands and rapidly expelled from these during skin penetration [45,46]; however, this 683 
transient expression and secretion into the host tissues is clearly insufficient to induce 684 
detectable antibodies in the early weeks following a primary infection. Most reports agree 685 
that Sm16 is not expressed by adult worms [9–12,46]. Although we detected low levels of 686 
Sm16 expression in female adult and mixed-adult extracts by qPCR in this study, we presume 687 
that this is due to some residual presence of eggs in adult female worms as no expression was 688 
found in male worms.  689 
 690 
Our finding that Sm16 is expressed in eggs disagrees with most earlier studies and the more 691 
recent report by Bernardes et al. [12]. The discrepancy may be because we employed more 692 
sensitive methods of Western blots (chemiluminescence) and gene amplification by qPCR. 693 
This would also explain why our results are consistent with studies by Gobert et al. [11] who 694 
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showed using microarrays that S. japonicum Sj16 is enriched in eggs. Our 695 
immunohistochemistry studies also clearly showed the presence of Sm16 within the 696 
unembryonated miracidium. This raises the possibility that Sm16 is involved in egg-driven 697 
immunomodulation and while we did not observe Sm16 in the tissues surrounding the egg, 698 
the presence of a signal peptide in the molecule and antibodies to Sm16 in the blood of 699 
infected mice suggests that it is secreted. Although antibodies were not detected until 700 
sometime after week 10 post-infection this could be because the molecule is secreted in low 701 
levels, is poorly immunogenic due to its small size, or is secreted late in the entrapped egg. 702 
Also, there may be little or no response to Sm16 until the host immune system is exposed to 703 
the increasing number of eggs released by females or when tissue-lodged eggs die and 704 
degrade and their contents disperse into the tissues. Nevertheless, our studies encourage 705 
future investigations to determine if Sm16 plays a role in egg-induced inflammation, in 706 
down-modulating the egg granuloma (which occurs between 8 – 20 weeks after infection) 707 
and/or in facilitating the immune-dependent exit of eggs through the intestine [47]. 708 
 709 
Much of the research to date that has evaluated the function of Sm16 has been conducted 710 
using a recombinant formulation expressed in E. coli that either features a mutation with two 711 
alanine substitutions at positions 92 and 93 [13,14,44] or a truncation of the last 27 C-712 
terminal residues [12]. These modifications were made due to the inability to express soluble 713 
recombinant Sm16 in this prokaryotic system, perhaps owing to the amphipathic nature of the 714 
C-terminal section of the protein. However, we would argue that these modifications also 715 
compromised the native structure of the molecule and, more importantly, its immunological 716 
function since these alterations were made within the region that is critical for the 717 
immunomodulatory activity of HDM. Indeed, Robinson et al. [36] demonstrated that 718 
disruption of the C-terminal amphipathic -helical by substitution of a leucine for a proline 719 
resulted in its inability to bind lipid membranes and inhibit vacuolar ATPase. We report here 720 
that full-length Sm16 can be expressed and secreted in the eukaryotic methylotrophic yeast P. 721 
pastoris and that this recombinant, as well as a synthetic version, bound to macrophages and 722 
was endocytosed into the endosomal/lysosomal system like other HDMs [36]. Bernardes et 723 
al. [12] acknowledged that the failure of their recombinant Sm16 vaccine to promote parasite 724 
elimination could have been because it lacked the C-terminal 27 residues; therefore, a repeat 725 
of these trials with yeast-expressed or synthetic full-length Sm16 may be worthwhile. 726 
 727 
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Another anomaly we found between our studies and previously reported work regards the 728 
sequence identities between the Sm16 of S. mansoni and the homologs found in S. 729 
japoncium. In the report of the discovery of the Sj16 homolog in S. japonicum, Hu et al. [18] 730 
states that this molecule ‘shares 99% identity with Sm16 in its nucleotide sequence, and 731 
100% identity in its protein sequence’. A recombinant formulation of the molecule was 732 
produced, termed rSj16, and has been used in a number of studies [18-23, 48-52]. We show 733 
here with our in-depth analysis of the genomic data currently available that while Sm16 734 
represents a single copy gene in S. mansoni, three Sm16-like molecules exist in the genome 735 
of S. japonicum; however, none of the three Sj16s share 100% primary sequence identity 736 
with Sm16. The percentage identities of Sj16_1, Sj16_2 and Sj16_3 compared to Sm16 are 737 
66%, 63% and 38%, respectively. 738 
 739 
We opted to evaluate the bioactive properties of a chemically synthesized Sm16 as we have 740 
previously shown that HDMs bind LPS very strongly in solutions making it difficult to 741 
isolate them free of endotoxin [24]. The LPS-binding capacity of HDM have also been 742 
reported by Martinez-Sernandez et al. [43,53] and Kang et al. [54]. Chemically synthesized 743 
peptides have various production benefits compared to recombinantly-produced peptides 744 
including reduced costs, capacity to up-scale, increased purity, and are endotoxin free. Here 745 
we show that Sm16 (34-117) is readily internalized by the endocytic/lysosomal system of 746 
macrophages and causes significant changes to the transcription of genes that are primarily 747 
associated with immune responses. Macrophages are key players in the innate immune 748 
response to pathogens and are also pivotal in coordinating tissue repair [55,56]. In the early 749 
stages of infection innate immune responses are potently stimulated by schistosomes and 750 
typically a Th1-type inflammatory response is mounted by the host [6]. In light of our 751 
observations that Sm16 exhibits weak pro-inflammatory activity, these responses could be 752 
associated in part with the early and rapid release of an abundance of this molecule. Upon 753 
infection, schistosome larvae induce IL-12p40 secretion from dendritic cells and 754 
macrophages, a cytokine considered to be a key mediator of the cutaneous inflammation [57]. 755 
Furthermore, radiation-attenuated cercariae, which have a delayed migration through the 756 
skin, elicit an IL-12p40-mediated Th1 response that confers protection against further 757 
parasite invasion [58]. The treatment of macrophages with Sm16 (34-117) resulted in a 1.5-758 
fold increase (p= 0.03) in IL-12p40 transcripts (IL12B; S6 Table) which would support the 759 
idea that Sm16 secreted by schistosomulae during infection could contribute to the IL-12p40-760 
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mediated inflammatory response. In addition, it has been suggested that IL-12p40 also has 761 
the propensity to inhibit eosinophilia [59], which may facilitate unimpeded access for the 762 
worm into host vasculature. This weak but significant pro-inflammatory property of Sm16-763 
like HDMs has been previously overlooked in studies of its immunomodulatory activity as 764 
experiments involving macrophages treated with Sm16 alone were not performed or reported 765 
[14,18]. 766 
 767 
Sm16 (34-117) attenuated the pro-inflammatory responses of LPS-stimulated macrophages 768 
compared to LPS controls in a dose-dependent manner. This observation suggested that 769 
Sm16 (34-117) exposure arrests macrophage responses to TLR4 activation and is supported 770 
by the anti-inflammatory activity of Sm16-derived molecules, and other HDMs, in 771 
dampening responses to LPS [13,14,17,19,20,22,24,26,40,50-52]. Our results also confirm 772 
that the chemically synthesized Sm16 (34-117) retains the anti-inflammatory properties of 773 
Sm16 (and also binds anti-Sm16 antibodies in infected mice blood). However, an attempt to 774 
identify a shorter peptide sequence with similar activity to the parent molecule activity, albeit 775 
focused around the -helical hotspots in the C-terminal region, was not successful and 776 
suggests that the intrinsic property of the Sm16 to be taken up by cells and alter their 777 
transcriptional profile is dependent on several conjoined motifs.  However, in light of the 778 
immunotherapeutic potential of Sm16, we have established that the synthetic Sm16 (34-117) 779 
is bioactive and can be used in future studies to elucidate Sm16 function as well as being a 780 
cost-effective option for further bio-therapeutics development. 781 
 782 
Analysis of cytokine production by human acute monocytic leukaemia THP-1 macrophages 783 
stimulated with Sm16 and with LPS showed that both induced pro-inflammatory responses, 784 
although the latter exhibit far higher potency. Microarray analysis of these cells found that of 785 
the 1217 genes that showed a significant change in expression when stimulated with Sm16 786 
(34-117), 65% (795) overlapped with the genes also significantly changed by LPS 787 
stimulation, with comparable up or down expression of genes. However, Sm16 exclusively 788 
altered the expression of 422 genes (35%) that were most highly associated with cellular 789 
movement and development, inflammatory responses and tissue morphology, and according 790 
to Ingenuity Pathway Analysis (IPA) were likely to elicit an increase in lymphocyte 791 
populations, increase cell viability, cellular movement and phagocytosis, in addition to 792 
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decreasing myeloid cell populations and inflammatory responses. The data therefore indicates 793 
that while Sm16 (34-117) displays pro-inflammatory activity with similarities to LPS its 794 
effect on macrophage cell activation and signalling was distinct. 795 
 796 
Interrogation of the RNA microarray data of Sm16 (34-117)-treated THP-1 macrophages 797 
suggested that at least one mechanism utilised by Sm16 to regulate the response of 798 
macrophages to activation by inflammatory ligands (such as LPS) was via the control of 799 
ligand-activated transcription factors PPAR and LXR. These nuclear receptors compete to 800 
hetero-dimerise with RXR before binding to DNA response elements in the promoter regions 801 
of target genes that control macrophage lipid, cholesterol and glucose homeostasis [38,39]. 802 
PPAR/LXR are expressed by a wide range of hematopoietic immune cells, including 803 
macrophages, and are known to have immunosuppressive effects on both the innate and 804 
adaptive arms of the mammalian immune response. They can alter gene expression to inhibit 805 
inflammatory cytokine transcription and the development of CD4+ T cells, and have also 806 
been linked to parasite-mediated immune modulation [60]. In this study, PPAR/LXR 807 
signaling was activated when the human macrophages were treated with the combination of 808 
LPS and Sm16 (34-117) which could suggest that this is a mechanism through which the 809 
peptide exerts its anti-inflammatory effects. Interestingly, using microarrays, Tanaka et al. 810 
[26] recently showed that blocking of LPS-induced inflammatory responses in murine 811 
(Balb/c) bone-marrow derived macrophages by a synthetic F. hepatica HDM also involved in 812 
the activation of PPAR/LXR signaling. In vivo experiments performed by Wang et al. [23] 813 
showed that rSj16 delivery protected mice from DSS-induced colitis which correlated with 814 
the inhibition of PPAR- signaling in the colon. Therefore, further investigation into the 815 
intricacies of Sm16 control of PPAR/LXR signaling, the implications of its effects on 816 
inflammatory responses, and indeed the affected cell-types that orchestrate the 817 
immunomodulation in vivo is warranted. 818 
 819 
The secretion of antigens by helminth parasites may inhibit endotoxin-induced inflammation 820 
to dampen Th1-type responses and indirectly promote a Th2 environment in which 821 
endoparasitic helminths can thrive [61–63]. However, the immune system 822 
modulation/polarisation exerted by flatworms and other helminth infections can leave hosts 823 
more susceptible to secondary infections that could potentially be deleterious for both the 824 
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host and parasite [64–66]. We have suggested that dampening classical immune activation by 825 
endotoxin with secreted molecules could be a mechanism employed by trematodes like F. 826 
hepatica and S. mansoni to confer tolerance to secondary bacterial infections [67]. A feature 827 
of these infections is the disruption of anatomical barriers, either at the skin, intestine, bladder 828 
or bile ducts which could lead to the translocation of bacteria into the host circulation and 829 
cause septicaemia and septic shock. Indeed, a study has shown that systemic endotoxin levels 830 
in individuals with schistosomiasis were extremely high, notably higher than lethal endotoxin 831 
levels reported in cases of septic shock [68]. Accordingly, secretion of HDM by these 832 
flatworms may be important in sustaining a general dampening of pro-inflammatory 833 
responses to co-infection with microbial pathogens, possibly via activation of PPAR and 834 
LXR/RXR transcription factors. 835 
 836 
In conclusion, we have shown that Sm16 and its homologues within the Schistosomatoidea 837 
superfamily are distinct members of the HDM family of short secretory peptides that are 838 
expressed exclusively by trematode species. Thus, our studies elevate the general importance 839 
of HDMs as a bone fide family of immunomodulatory molecules in these globally important 840 
parasites of humans and their livestock. In the context of the collective published data, our 841 
study broadens our understanding of Sm16-like molecules and supports the idea that they 842 
play an important role in key host-parasite interactions including the 843 
scavenging/detoxification of haemoglobin-derived heme and iron transport [43,53] while also 844 
advancing the proposal that the secretion of Sm16 by eggs could contribute to disease 845 
pathogenesis and/or transmission. However, further research, for example through specific 846 
gene knock-down and/or gene editing, would go a long way towards elucidating the true 847 
importance of Sm16 in schistosomiasis. Finally, as we have shown that a synthetic form of 848 
this molecule, Sm16 (34-117), retains bioactive and immunomodulatory properties which 849 
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 1112 
SUPPORTING INFORMATION 1113 
S1 Fig. Structural analyses of the Schistosomatidae-specific family of Sm16-like 1114 
molecules. (A) A MAFFT amino acid alignment of the Sm16-like proteins from trematodes. 1115 
The predicted signal peptide is shown underlined and in italics. The black line depicts the 1116 
area of the Sm16-like molecules that is amphipathic. The four colour blocks represent the 1117 
sequence encoded by the four exons depicted in the genomic organisation below.  (B) 1118 
Schematic representation of the genomic organisation of the Sm16-like molecules. Exons and 1119 
introns are represented as coloured boxes and lines, respectively. The numbers denote the 1120 
number of nucleotide base pairs. ^Sr16 gene – Part of the last exon is missing due to an error 1121 
in the Schistosoma rodhaini genome scaffold. *Sh16 gene – The second intron cannot be 1122 
determined within the current Schistosoma haematobium genome assembly; currently the 1123 
first two exons are present on the forward DNA strand, with the remaining part of the gene 1124 
present on the opposite strand of the scaffold. ±As the Sj16_2 and Tr16_2 genes are present 1125 
at the beginning of their respective scaffolds the first exon cannot be determined within the 1126 
current genome assemblies.  1127 
 1128 
S2 Fig. Structural analyses of the Trematode-specific family of Fasciola-like HDM 1129 
molecules. (A) A MAFFT amino acid alignment of the Fasciola-like HDM proteins. The 1130 
predicted signal peptide is shown underlined and in italics. The four colour blocks represent 1131 
the sequence encoded by the four exons depicted in the genomic organisation below.  (B) 1132 
Schematic representation of the genomic organisation of the Fasciola-like HDM molecules. 1133 
Exons and introns are represented as coloured boxes and lines, respectively. The numbers 1134 
denote the number of nucleotide base pairs. ^As the TrHDM gene is present at the beginning 1135 




S3 Fig. Purification of yeast-expressed recombinant Sm16. Top: gene accession numbers 1139 
of Sm16/SPO-1 and primary sequence. The signal sequence is shaded in black. The DNA 1140 
sequence encoding Sm16 without the signal sequence was cloned into a pPinkα-HC vector 1141 
and expressed in Pichia pastoris as a secreted 6xHis-tagged protein. Recombinant Sm16 was 1142 
purified using Ni2+-affinity chromatography and analysed on a 16% SDS-PAGE 1143 
electrophoresis gel which was subsequently stained with Coomassie blue. Sm16 was also 1144 
detected using anti-His tag and anti-Sm16 antibodies.  1145 
 1146 
S4 Fig. Biological processes associated with genes independently affected by Sm16. IPA 1147 
of 422 genes differentially up- regulated >1.5 fold (p <0.05) in macrophages by treatment 1148 
with Sm16 and independent of genes associated with the cellular response to LPS, 1149 
represented as log p value. The orange line highlights the threshold of –log(0.05) / 1.3. 1150 
 1151 
S5 Fig. Comparative analyses of the biological effects exerted by Sm16 (34-117) and 1152 
LPS as shown by differential gene expression. THP-1 macrophages (2.5 x 105) were 1153 
untreated or treated with Sm16 (34-117) alone (20 μg/ml), LPS alone (100 ng/ml) or with 1154 
both Sm16 (34-117) and LPS for 4 hrs before extracting RNA for analysis using Illumina 1155 
HT12 V.4 Expression Bead Chips. Significantly differentially expressed genes were 1156 
identified by ANOVA and IPA analysis of these produced predicted effects on associated 1157 
functions. Inhibition and activation of pathways are shown by the z-score, represented by a 1158 
scale of blue to orange, respectively. 1159 
 1160 
S1 Table. Accession number/protein identifiers of the sequences used for the 1161 
phylogenetic analysis.  1162 
 1163 
S2 Table: Details of parasite genome databases and seed sequences used for BLAST 1164 
analysis 1165 
 1166 
S3 Table. Cytokine array analysis of supernatants of THP-1 macrophages that were 1167 
untreated or treated with Sm16 (34-117), LPS or LPS and Sm16 (34-117). Numbers 1168 
represent fold change in cytokine signal. Signal intensity was measured by densitometry. 1169 
When comparing separate membranes values were normalised using a comparative ratio 1170 
calculated using densitometry values for membrane positive control spots. 1171 
 38 
 1172 
S4 Table: Top 70 genes differentially regulated by adding Sm16 to THP-1 macrophages. 1173 
 1174 
S5 Table: Top 70 genes differentially regulated by adding Sm16 to LPS-treated THP-1 1175 
macrophages. 1176 
 1177 
S6 Table: Differential expression analyses by microarray of THP-1 macrophages 1178 
treated with Sm16 and LPS. 1179 
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